What Makes Us Different
We Accept Most Major Insurances
What We Believe
Non-Invasive
Therapy
Holistic
Approach
Patient-Centered
Practice
Spravato (esKetamine)
Spravato is the brand name for esketamine, an FDA-approved medication since March 2019 for the treatment of treatment-resistant depression (TRD) and Major Depression with suicidal ideation in adults. Treatment-resistant depression is characterized by a lack of adequate response to at least two different antidepressant treatments.
For adults experiencing Major Depressive Disorder (MDD) who have attempted two or more antidepressants without success, Spravato presents itself as a viable option. Administered via nasal spray, it is meant to complement oral antidepressant therapy.
Spravato works differently than other medications for treatment-resistant depression.
TMS Therapy
Refresh TMS uses NeuroStar® Advanced Therapy, which is a patented TMS technology that utilizes a magnetic coil to stimulate regions of the brain associated with depression symptoms.
TMS Therapy is now FDA-Cleared for ages 15 and older, as an adjunct (add-on) to your existing therapy. Nearly 10,000 adolescents have been treated with over 300,000 NeuroStar sessions.
